Inventor · disambiguated record
Benjamin Ebert
Also filed as: EBERT BENJAMIN · EBERT BENJAMIN L · EBERT BENJAMIN LEVINE
17 granted patents·15 pending applications·13 citations·filing 2009–2025
89Inventor score
Files withBROAD INST INC9BRIGHAM & WOMENS HOSPITAL INC8MASSACHUSETTS GEN HOSPITAL4DANA FARBER CANCER INST INC2GEN HOSPITAL CORP2
Top patents by PatentIndex Score
32 records- 0187US11788144B2Methods of identifying and treating a person having a predisposition to or afflicted with a cardiometabolic diseaseBRIGHAM & WOMENS HOSPITAL INC·Filed 2021·Granted Oct 17, 2023·1 cites·12 claims
- 0284US11168369B2Method of identifying and treating a person having a predisposition to or afflicted with a cardiometabolic diseaseBRIGHAM & WOMENS HOSPITAL INC·Filed 2015·Granted Nov 9, 2021·2 cites·23 claims
- 0383US12503733B2Methods of identifying and treating a person having a predisposition to or afflicted with a cardiometabolic diseaseBRIGHAM & WOMENS HOSPITAL INC·Filed 2023·Granted Dec 23, 2025·0 cites·12 claims
- 0483US10334829B2IMiD screening methods IMiD-sensitive cells with mutant CRBNBROAD INST INC·Filed 2018·Granted Jul 2, 2019·2 cites·9 claims
- 0582US9974289B2Knock-in rodent comprising a mutation in an endogenous CRBN locus and methods of use thereofBROAD INST INC·Filed 2016·Granted May 22, 2018·2 cites·14 claims
- 0678US11168345B2Methods of identifying a polypeptide target for degradation by a modulator of CRBNMIKKELSEN TARJEI·Filed 2016·Granted Nov 9, 2021·2 cites·9 claims
- 0775US12049482B2Molecular switch-mediated control of engineered cellsMASSACHUSETTS GEN HOSPITAL·Filed 2018·Granted Jul 30, 2024·1 cites·16 claims
- 0875US11304938B2Compositions and methods for treating chemotherapy resistant cancerBRIGHAM & WOMENS HOSPITAL INC·Filed 2017·Granted Apr 19, 2022·1 cites·10 claims
- 0975US2025215497A1IL-8, IL-6, IL-1 Beta and TET2 and DNMT3A in AtherosclerosisTHE BRIGHAM AND WOMEN’S HOSPITAL INC·Filed 2024·Application pending·0 cites
- 1069US2025074957A1Molecular switch-mediated control of engineered cellsMASSACHUSETTS GEN HOSPITAL·Filed 2024·Application pending·0 cites
- 1168US11785925B2Disease biomarkers and treatment methods related theretoBROAD INST INC·Filed 2019·Granted Oct 17, 2023·0 cites·16 claims
- 1263US12201620B2Compositions and methods for treating chemotherapy resistant cancerBRIGHAM & WOMENS HOSPITAL INC·Filed 2022·Granted Jan 21, 2025·0 cites·17 claims
- 1363US2022017938A1Methods of identifying drug-modulated polypeptide targets for degradationBROAD INST INC·Filed 2021·Application pending·0 cites
- 1462US8828965B2MiR-150 for the treatment of blood disordersGEN HOSPITAL CORP·Filed 2013·Granted Sep 9, 2014·0 cites·7 claims
- 1562US2009202493A1Mir-150 for the treatment of blood disordersGEN HOSPITAL CORP·Filed 2009·Application pending·0 cites
- 1662US2019106710A1Oncogenic Models Based on Delivery and Use of the CRISPR-Cas Systems, Vectors and CompositionsBROAD INST INC·Filed 2018·Application pending·0 cites
- 1761US10711308B2Mutation signatures for predicting the survivability of myelodysplastic syndrome subjectsBEJAR RAFAEL·Filed 2012·Granted Jul 14, 2020·1 cites·31 claims
- 1860US8530443B2miR-150 for the treatment of blood disordersLU JUN·Filed 2012·Granted Sep 10, 2013·0 cites·5 claims
- 1959US2016282354A1Compositions and methods for selecting a treatment for b-cell neoplasiasBROAD INST INC·Filed 2014·Application pending·0 cites
- 2055US9164094B2Biomarkers to identify HIV-specific T-cell subsetsHAINING W NICHOLAS·Filed 2012·Granted Oct 20, 2015·1 cites·13 claims
- 2155US2020131576A1IL-8, IL-6, IL-1 Beta and TET2 and DNMT3A in AtherosclerosisBRIGHAM & WOMENS HOSPITAL INC·Filed 2018·Application pending·0 cites
- 2255US2022281931A1Chemically inducible polypeptide polymerizationDANA FARBER CANCER INST INC·Filed 2022·Application pending·0 cites
- 2353US2022275079A1Clonal Hematopoiesis and Risk of Chronic Liver DiseaseMASSACHUSETTS GEN HOSPITAL·Filed 2021·Application pending·0 cites
- 2450US2016168594A1Oncogenic models based on delivery and use of the crispr-cas systems, vectors and compositionsBROAD INST INC·Filed 2015·Application pending·0 cites
- 2550US2023151342A1Zinc finger degradation domainsBROAD INST INC·Filed 2021·Application pending·0 cites
- 2649US2022098251A1Peptide tags for ligand induced degradation of fusion proteinsDANA FARBER CANCER INST INC·Filed 2019·Application pending·0 cites
- 2749US2013338092A1Compounds and methods for targeting leukemic stem cellsBROAD INST INC·Filed 2013·Application pending·0 cites
- 2848US2025241955A1Engineered bifunctional receptors and uses thereofMASSACHUSETTS GEN HOSPITAL·Filed 2025·Application pending·0 cites
- 2947US11015223B2Methods for determining response to a hypomethylating agentUNIV CALIFORNIA·Filed 2014·Granted May 25, 2021·0 cites·7 claims
- 3045US11426405B2Inhibition of JAK-STAT signaling inhibits formation of neutrophil extracellular traps (NETs)BRIGHAM & WOMENS HOSPITAL INC·Filed 2018·Granted Aug 30, 2022·0 cites·10 claims
- 3143US11459613B2Methods of characterizing resistance to modulators of CereblonBRIGHAM & WOMENS HOSPITAL INC·Filed 2016·Granted Oct 4, 2022·0 cites·15 claims
- 3229US2012237488A1Lsc and hsc signatures for predicting survival of patients having hematological cancerDICK JOHN·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Benjamin Ebert files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →